ArticleQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2026
Development of the Japanese version of the Manchester short assessment of quality of life (MANSA) among people with self-reported severe mental illness.
Article in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe Manchester Short Assessment of Quality of Life (MANSA) is a quality-of-life (QOL) instrument developed for people with mental illness. This study aimed to develop a Japanese version of the MANSA for people with severe mental illness (SMI) and examine associations between individual MANSA domains and psychiatric diagnosis.
methodsThe MANSA includes 12 self-rated subjective QOL items; the overall score is their mean on a 1-7 scale. We prepared a Japanese translation and tested validity and reliability using cross-sectional survey data from 237 adults with SMI in Japan. Concurrent validity was tested in 38 respondents who also completed the WHOQOL26. The sample was randomly split for exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) in separate subsamples. Analyses included score distributions, validity, internal consistency, and domain-level ordinal logistic regression.
resultsThe MANSA items showed the expected associations with the relevant scales and items. Although a two-factor structure was supported by EFA, the CFA fit indices were CFI = 0.86, TLI = 0.82, and RMSEA = 0.12. In the one-factor EFA solution, all factor loadings exceeded 0.40. Cronbach's alpha for all 12 items was 0.877. The schizophrenia-spectrum group had higher scores in several domains than the bipolar- and depressive-disorder groups, and symptom stability was associated with higher scores across all domains.
conclusionsThe Japanese version of MANSA showed acceptable concurrent validity and internal consistency. The proposed two-factor structure was not supported; total-score use remained reasonable, but further validation is needed. Diagnosis and symptom stability were associated with domain-specific QOL.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.